Researchers at the University at Buffalo have described a novel pathway by which estradiol, the primary estrogen in humans, aids in maintaining bone density, a function critical to avoiding osteoporosis.
More than 325,000 tummy tuck, breast augmentation and breast lift procedures were performed on women ages 20-39 in 2006, according to statistics released by the American Society of Plastic Surgeons (ASPS).
Tissue engineering is a relatively new field of basic and clinical science that is concerned, in part, with creating tissues that can augment or replace injured, defective, or diseased body parts.
Sutent (sunitinib malate) has received a European Association of Urology recommendation, as first-line therapy in patients with metastatic renal cell carcinoma of good and intermediate risk, just two months after gaining EU marketing authorization for first line use in all patients with advanced and/or metastatic renal cell carcinoma.
In Genome Research, a husband-and-wife research team from Thomas Jefferson University report the discovery of a gene that, when mutated, may suppress colorectal cancer.
The Alzheimer’s Association reports that in 2007 there are now more than 5 million people in the United States living with Alzheimer’s disease. Someone develops Alzheimer?s every 72 seconds, according to new Alzheimer?s Association report.
To establish circadian cell cycle rhythms, cell-autonomous clock mechanisms act in concert with a systemic signaling environment of which glucocorticoids are an essential part.
People who use tanning beds do not protect themselves from skin damage from subsequent sun exposure. Use of sunbeds before age 35 substantially increases the risk of developing melanoma, the most deadly type of skin cancer, the researchers found.
A newly discovered small molecule called IQ-1 plays a key role in preventing embryonic stem cells from differentiating into one or more specific cell types, allowing them to instead continue growing and dividing indefinitely, according to research performed by a team of scientists who have recently joined the stem-cell research efforts at the Keck School of Medicine of the University of Southern California.
New non-toxic and targeted therapies for metastatic breast and ovarian cancers may now be possible, thanks to a discovery by a team of researchers at the University of British Columbia.